STOCK TITAN
  1. Home
  2. Sec-filings
  3. NERV
  4. [EFFECT] Minerva Neurosciences, Inc. SEC Filing

[EFFECT] Minerva Neurosciences, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 19, 2026 4:00 P.M.
Form: S-3
CIK: 0001598646
Company Name: Minerva Neurosciences, Inc.
File Number: 333-294203

Source: View Original Filing on SEC EDGAR

Minerva Neurosci

NASDAQ:NERV

View NERV Stock Overview →

NERV Rankings

#3839 Ranked by Market Cap
N/A Ranked by Dividends
#35 Top Loser

NERV Latest News

Mar 12, 2026
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
Mar 11, 2026
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Mar 4, 2026
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
Jan 26, 2026
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
Nov 19, 2025
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors

NERV Latest SEC Filings

Mar 10, 2026
[144] Minerva Neurosciences, Inc. SEC Filing
Mar 10, 2026
[144] Minerva Neurosciences, Inc. SEC Filing
Mar 10, 2026
[144] Minerva Neurosciences, Inc. SEC Filing
Mar 11, 2026
[S-3] Minerva Neurosciences, Inc. Shelf Registration Statement
Mar 11, 2026
[10-K] Minerva Neurosciences, Inc. Files Annual Report

NERV Stock Data

349.22M
5.44M
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGTON